tiprankstipranks
Aptose Biosciences Clarifies Regulatory Compliance Measures
PremiumCompany AnnouncementsAptose Biosciences Clarifies Regulatory Compliance Measures
1M ago
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
PremiumPress Releases
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
1M ago
APTO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
APTO Upcoming Earnings Report: What to Expect?
1M ago
Aptose Biosciences prices 4.9M shares at $1.71 in underwritten public offering
PremiumThe FlyAptose Biosciences prices 4.9M shares at $1.71 in underwritten public offering
3M ago
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
PremiumPress Releases
Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical
3M ago
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
4M ago
Aptose Biosciences files to sell 4.1M shares of common stock, warrants
PremiumThe FlyAptose Biosciences files to sell 4.1M shares of common stock, warrants
5M ago
Aptose names Fletcher Payne chief business officer
PremiumThe Fly
Aptose names Fletcher Payne chief business officer
5M ago
Aptose Biosciences price target lowered to $18 from $23 at RBC Capital
PremiumThe Fly
Aptose Biosciences price target lowered to $18 from $23 at RBC Capital
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100